HYTN Innovations Inc (TSE:HYTN)
:HYTN
Top Page
HYTN Innovations Inc
(HYTN)
Select Model
Select Model
Rating:53Neutral
Price Target:
C$0.25
▼(-4.23% Downside)
Action:ReiteratedDate:03/27/26
The score is held back primarily by weak financial performance—heavy losses, very thin gross margin, negative equity, and still-negative free cash flow—despite strong recent revenue growth and improved operating cash flow. Technicals are a key offset, with the stock trading above major moving averages and showing moderately positive momentum. Valuation is also a drag due to the negative P/E and lack of dividend yield data.
Positive Factors
Strong recent revenue growth
A ~75.6% TTM revenue rebound to ~$2.94M signals durable commercial traction and improving product-market fit. Sustained top-line growth provides a foundation to leverage fixed costs, negotiate better supplier terms, and support future margin recovery if volume trends continue.
Negative Factors
Very thin gross margin
A gross margin near 5.6% severely constrains the company's ability to cover SG&A and R&D, limiting long-term profitability. Low margin reflects weak pricing power or high COGS, making the business highly sensitive to input-cost inflation and requiring major efficiency or price moves to reach sustainable profits.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong recent revenue growth
A ~75.6% TTM revenue rebound to ~$2.94M signals durable commercial traction and improving product-market fit. Sustained top-line growth provides a foundation to leverage fixed costs, negotiate better supplier terms, and support future margin recovery if volume trends continue.
Read all positive factors
HYTN Innovations Inc (HYTN) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$22.49M
Dividend YieldN/A
Average Volume (3M)12.09K
Price to Earnings (P/E)―
Beta (1Y)-0.92
Revenue Growth47.86%
EPS Growth-225.43%
CountryCA
Employees7
SectorConsumer Defensive
Sector Strength42
IndustryBeverages - Alcoholic
Share Statistics
EPS (TTM)N/A
Shares Outstanding93,708,110
10 Day Avg. Volume8,619
30 Day Avg. Volume12,093
Financial Highlights & Ratios
PEG Ratio0.13
Price to Book (P/B)-14.08
Price to Sales (P/S)9.42
P/FCF Ratio-26.71
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
HYTN Innovations Inc Business Overview & Revenue Model
Company Description
HYTN Innovations Inc. engages in the research, production, marketing, distribution, and sale of cannabis products for recreational consumers in Canada. It intends to offer infused sparkling beverages and infused edibles in various flavors. The com...
How the Company Makes Money
null...
HYTN Innovations Inc Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
12
Very Negative
Cash Flow
22
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Sep 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.67M | 851.49K | 763.46K | 696.36K | 0.00 |
| Gross Profit | 93.23K | 287.44K | 91.85K | 121.65K | 0.00 |
| EBITDA | -1.12M | -6.26M | -1.45M | -9.88M | -745.51K |
| Net Income | -1.52M | -6.61M | -2.33M | -17.38M | -959.48K |
Balance Sheet | |||||
| Total Assets | 3.62M | 2.38M | 2.58M | 3.79M | 2.76M |
| Cash, Cash Equivalents and Short-Term Investments | 345.10K | 256.58K | 187.56K | 1.03M | 264.06K |
| Total Debt | 2.04M | 793.56K | 919.74K | 887.22K | 2.58M |
| Total Liabilities | 4.74M | 2.56M | 2.27M | 1.71M | 2.77M |
| Stockholders Equity | -1.12M | -172.97K | 314.72K | 2.07M | -8.88K |
Cash Flow | |||||
| Free Cash Flow | -590.49K | -804.21K | -1.18M | -2.38M | -1.67M |
| Operating Cash Flow | -572.27K | -783.36K | -1.18M | -2.16M | -693.52K |
| Investing Cash Flow | -15.92K | 162.67K | -4.10K | 2.19M | -1.02M |
| Financing Cash Flow | 676.12K | 689.71K | 346.17K | 727.93K | 1.80M |
HYTN Innovations Inc Technical Analysis
Neutral
0.26
Price Trends
0.25
Negative
0.21
Positive
0.19
Positive
Market Momentum
>-0.01
Positive
48.10
Neutral
33.95
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:HYTN, the sentiment is Neutral. The current price of 0.26 is above the 20-day moving average (MA) of 0.25, above the 50-day MA of 0.25, and above the 200-day MA of 0.19, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 48.10 is Neutral, neither overbought nor oversold. The STOCH value of 33.95 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for TSE:HYTN.
HYTN Innovations Inc Peers Comparison
UnderperformOutperform
Sector (62)
TSE:HYTN
HYTN Innovations Inc
0.24
0.04
20.00%
TSE:CGII
CleanGo Innovations
0.55
0.20
57.14%
TSE:HYPE
Hemp for Health Inc
0.16
-0.26
-61.90%
TSE:MUSL
Element Nutritional Sciences Inc
0.04
-0.01
-20.00%
TSE:PTFY
Plantify Foods Inc
0.10
-0.30
-75.64%
HYTN Innovations Inc Corporate Events
Business Operations and StrategyProduct-Related Announcements
HYTN secures German cannabis market foothold with product release and reorder
Positive
Mar 27, 2026
HYTN Innovations Inc., a pharmaceutical manufacturer focused on psychoactive and cannabis-based products for federally regulated markets, leverages GMP-compliant processes to supply pharmaceutical-grade cannabinoids. The company targets tightly co...
Business Operations and StrategyExecutive/Board Changes
HYTN Adds Former Gage CEO to Board, Extends Investor Marketing Push
Positive
Mar 21, 2026
Cannabis-focused pharmaceutical manufacturer HYTN Innovations Inc. has appointed technology entrepreneur and investor Fabian Monaco to its board of directors, adding deep experience in capital markets, MA, and scaling high-growth businesses. Monac...
Business Operations and Strategy
HYTN Hires German Firm MCS to Boost Investor-Focused Marketing
Positive
Jan 10, 2026
HYTN Innovations Inc. has engaged Germany-based MCS Market Communication Service GmbH to deliver a roughly 60-day marketing and communications program aimed at increasing investor and market awareness of the cannabis-focused pharmaceutical manufac...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.